Show simple item record

dc.contributor.authorFullagar, Simoneen_US
dc.contributor.authorO'Brien, Wendyen_US
dc.contributor.editorMichael Traynoren_US
dc.date.accessioned2017-05-03T14:23:03Z
dc.date.available2017-05-03T14:23:03Z
dc.date.issued2013en_US
dc.date.modified2014-08-28T22:14:15Z
dc.identifier.issn13634593en_US
dc.identifier.doi10.1177/1363459312447255en_US
dc.identifier.urihttp://hdl.handle.net/10072/47442
dc.description.abstractIn this article we situate empirical research into women's problematic experiences of anti-depressant medication within broader debates about pharmaceuticalization and the rise of the neurochemical self. We explore how women interpreted and problematized anti-depressant medication as it impeded their recovery in a number of ways. Drawing upon Foucauldian and feminist work we conceptualize anti-depressants as biotechnologies of the self that shaped how women thought about and acted upon their embodied (and hence gendered) subjectivities. Through the interplay of biochemical, emotional and socio-cultural effects medication worked to shape women's self-inrecovery in ways that both reinscribed and undermined a neurochemical construction of depression. Our analysis outlines two key discursive constructions that focused on women's problematization of the neurochemical self in response to the side-effects of anti-depressant use. We identified how the failure of medication to alleviate depression contributed to women's reinterpretation of recovery as a process of 'working' on the emotional self. We argue that women's stories act as a form of subjugated knowledge about the material and discursive forces shaping depression and recovery. These findings offer a gendered critique of scientific and market orientated rationalities underpinning neurochemical recovery that obscure the embodied relations of affect and the social conditions that enable the self to change.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_US
dc.format.extent481107 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglishen_US
dc.language.isoen_US
dc.publisherSageen_US
dc.publisher.placeUnited Kingdomen_US
dc.relation.ispartofstudentpublicationNen_US
dc.relation.ispartofpagefrom57en_US
dc.relation.ispartofpageto74en_US
dc.relation.ispartofissue1en_US
dc.relation.ispartofjournalHealth: An interdisciplinary journal for the social study of health, illness and medicineen_US
dc.relation.ispartofvolume17en_US
dc.rights.retentionYen_US
dc.subject.fieldofresearchMental Healthen_US
dc.subject.fieldofresearchSociology not elsewhere classifieden_US
dc.subject.fieldofresearchcode111714en_US
dc.subject.fieldofresearchcode160899en_US
dc.titleProblematizing the neurochemical subject of anti-depressant treatment: The limits of biomedical responses to women’s emotional distressen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.facultyGriffith Business School, Department of Tourism, Sport and Hotel Managementen_US
gro.rights.copyrightCopyright 2012 SAGE Publications. This is the author-manuscript version of the paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.en_US
gro.date.issued2013
gro.hasfulltextFull Text


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record